Your browser doesn't support javascript.
loading
Amelioration effects of the soybean lecithin-gallic acid complex on iron-overload-induced oxidative stress and liver damage in C57BL/6J mice.
Wu, Caihong; Zhang, Wenxin; Yan, Feifei; Dai, Wenwen; Fang, Fang; Gao, Yanli; Cui, Weiwei.
Afiliação
  • Wu C; Department of Nutrition and Food Hygiene, School of Public Health, Jilin University, Changchun, China.
  • Zhang W; Department of Pathogenobiology, Jilin University Mycology Research Center, College of Basic Medical Sciences, Jilin University, Changchun, China.
  • Yan F; Department of Nutrition and Food Hygiene, School of Public Health, Jilin University, Changchun, China.
  • Dai W; Department of Nutrition and Food Hygiene, School of Public Health, Jilin University, Changchun, China.
  • Fang F; Department of Nutrition and Food Hygiene, School of Public Health, Jilin University, Changchun, China.
  • Gao Y; Department of Pediatric Ultrosonic, The First Hospital of Jilin University, Changchun, China.
  • Cui W; Department of Nutrition and Food Hygiene, School of Public Health, Jilin University, Changchun, China.
Pharm Biol ; 61(1): 37-49, 2023 Dec.
Article em En | MEDLINE | ID: mdl-36573499
ABSTRACT
CONTEXT Gallic acid (GA) and lecithin showed important roles in antioxidant and drug delivery, respectively. A complex synthesized from GA and soybean lecithin (SL-GAC), significantly improved bioavailability of GA and pharmacological activities. However, the antioxidant activity of SL-GAC and its effect on iron-overload-induced liver injury remains unexplored.

OBJECTIVE:

This study investigates the antioxidant properties of SL-GAC in vitro and in mice, and its remediating effects against liver injury by iron-overloaded. MATERIALS AND

METHODS:

In vitro, free radical scavenging activity, lipid peroxidation inhibition, and ferric reducing power of SL-GAC were measured by absorbance photometry. In vivo, C57BL/6J mice were randomized into 4 groups control, iron-overloaded, iron-overloaded + deferoxamine, and iron-overloaded + SL-GAC. Treatments with deferoxamine (150 mg/kg/intraperitioneally) and SL-GAC (200 mg/kg/orally) were given to the desired groups for 12 weeks, daily. Iron levels, oxidative stress, and biochemical parameters were determined by histopathological examination and molecular biological techniques.

RESULTS:

In vitro, SL-GAC showed DPPH and ABTS free radicals scavenging activity with IC50 values equal to 24.92 and 128.36 µg/mL, respectively. In C57BL/6J mice, SL-GAC significantly reduced the levels of serum iron (22.82%), liver iron (50.29%), aspartate transaminase (25.97%), alanine transaminase (38.07%), gamma glutamyl transferase (42.11%), malondialdehyde (19.82%), total cholesterol (45.96%), triglyceride (34.90%), ferritin light chain (18.51%) and transferrin receptor (27.39%), while up-regulated the levels of superoxide dismutase (24.69%), and glutathione (11.91%).

CONCLUSIONS:

These findings encourage the use of SL-GAC to treat liver injury induced by iron-overloaded. Further in vivo and in vitro studies are needed to validate its potential in clinical medicine.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobrecarga de Ferro / Hepatopatias Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobrecarga de Ferro / Hepatopatias Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article